Skip to content

 

Advanced healthcare

Bradford has a leading reputation in dementia care research and the research and development of new cancer treatments. Investment and development into these two areas continues to be a priority for the University and for our society.

 

 

elderly woman and nurse laughing

 

Dementia care research

Bradford is recognised throughout the world for its work in dementia and end of life care – in 2016 our dementia team was awarded the coveted Queen’s Anniversary Prize

Our work is already having an impact: for example, our care programme for dementia patients has been proven to reduce falls and agitation, and now forms a key part of National Institute for Health & Care Excellence (NICE) guidelines. However, the health costs of dementia to the UK are already more than those of cancer, heart disease and stroke combined.

Bradford is tackling this through a Doctoral Training Centre within the Centre for Applied Dementia Studies. The Centre provides PhD students with the training, mentoring and support they need to develop new ideas and ways of integrating new technology into the lives of those living with dementia. 

We need funding for our PhD students to continue the work of the Doctoral Training Centre and create the dementia care researchers of tomorrow.

Cancer research, developing a new immunotherapy lab

Bradford is one of the few research centres nationally that has the facilities and expertise to progress anti-cancer medicines from concept to clinic.

In recent years our scientists have progressed three candidate cancer medicines into clinical trials and, thanks to the success of our £1 million Crocus Appeal, pioneered the ‘crocus flower smart bomb’ treatment which has the potential to destroy tumours without harming healthy tissue.

The immune system has long been known to have a potentially vital role to play in the battle against cancer. Radical scientific approaches now provide an opportunity, for the very first time, to harness the immune system to identify and fight tumour cells as they develop.

Funds to invest in a new immunotherapy laboratory and exceptional young research fellows are necessary to push forward these ideas.